Key result
Stepwise reduction of enalapril dosage from /d to /d caused no significant change in blood pressure, LV structure, LV systolic function, or QT dispersion.
Why the study?
Does stepwise reduction of enalapril dosage maintain normal blood pressure and cardiovascular control in patients with essential hypertension and LV hypertrophy previously normalized on high doses?
Observational (n=24)
Does stepwise reduction of enalapril dosage maintain normal blood pressure and cardiovascular control in patients with essential hypertension and LV hypertrophy previously normalized on high doses?
In hypertensive patients with LV hypertrophy normalized by prolonged high-dose enalapril, the dose can be safely reduced up to 8-fold without losing cardiovascular control, offering potential health cost benefits.
Answers are grounded in this paper and cite their sources.
May permit enalapril dose reduction in normalized LVH without BP or LV changes; extends observational data but leaves open randomized confirmation.
Enalapril treatment (20 mg every 12 hours) of 24 patients with essential hypertension and left ventricular (LV) hypertrophy established normal blood pressures after 8 weeks, and after 5 years, it had reduced LV mass index by 39% (from 148+/-34 to 90+/-16 g/m(2)) and had normalized LV structure and function and QT dispersion. Stepwise reduction of the enalapril dosage from 40 to 30, 20, 10, and 5 mg/d during the eighth year caused no significant change in blood pressure, LV structure, LV systolic function, or QT dispersion, which all likewise remained unaltered during an additional 2-year period of the 5-mg/d regimen. We conclude that for hypertensive patients in whom prolonged treatment with high doses of enalapril has normalized blood pressure, LV structure, LV function, and QT dispersion, the dose may be reduced as much as 8-fold without detriment to cardiovascular control. The use of smaller doses is evidently advantageous from the point of view of health costs.
No takes yet. Share an insight, caveat, or question.
González‐Juanatey et al. (1999) conducted an observational in essential hypertension and left ventricular (LV) hypertrophy (n=24). Stepwise reduction of enalapril dosage was evaluated on blood pressure, LV structure, LV systolic function, and QT dispersion. Stepwise reduction of enalapril dosage from /d to /d caused no significant change in blood pressure, LV structure, LV systolic function, or QT dispersion.
Synapse has enriched 10 related papers. Consider them for comparative context: